Companies / Cytokinetics Inc
Cytokinetics Inc
Financials · FY2025
Ownership
139.0M shares outstanding · as of Aug 4, 2026
Ownership
| Insiders | 0.72% | 1,004,076 |
| 10%+ / strategic | 25.37% | 35,273,606 |
| Institutions | 82.89% | 115,231,792 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 14
View all →| Insider | % of shares | Shares |
|---|---|---|
Blum Robert ICEOPresident & CEO · Director | 0.28% | 385,330 |
Malik Fady IbrahamEVP Research & Development | 0.11% | 153,902 |
Hessekiel JeffreyChief Legal & Admin Officer | 0.08% | 107,943 |
Henderson John TDirector | 0.06% | 78,088 |
Lee SungEVP, Chief Financial Officer | 0.05% | 63,221 |
Callos AndrewEVP, Chief Commercial Officer | 0.04% | 58,555 |
Wierenga WendellDirector | 0.03% | 35,488 |
Wysenski NancyDirector | 0.02% | 33,917 |
Bhanji MunaDirector | 0.02% | 26,361 |
Harrington Robert ArthurDirector | 0.02% | 21,781 |
Institutional holders 450
View all →| Holder | Value | % of shares |
|---|---|---|
| $1.71B | 14.45% | |
| $813.80M | 9.21% | |
| $765.54M | 8.67% | |
| $553.24M | 4.67% | |
| $504.32M | 5.71% | |
| $212.03M | 2.40% | |
| $211.97M | 2.31% | |
| $186.88M | 2.12% | |
| $172.90M | 1.96% | |
| $153.93M | 1.74% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | — | $315.14M | +3.7M +22.56% | 20,094,362 14.45% of shares | high |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | New | — | $65.42M | +993K | 992,545 0.71% of shares | high |
| Q2 2026 as of | State Street Corporation 13F manager | Add | — | $56.99M | +669K +11.48% | 6,494,233 4.67% of shares | high |
| Q1 2026 as of | Norges Bank 13F manager | Exit | — | $-51.28M | -807K -100.00% | — | high |
| Q1 2026 as of | D. E. Shaw & Co., Inc. 13F manager | Add | — | $38.72M | +587K +492.71% | 706,631 0.51% of shares | medium |
| Q2 2024 as of | Barclays PLC 13F manager | Trim | — | $-26.00M | -480K -62.95% | 282,378 0.20% of shares | medium |
| Q4 2025 as of | Norges Bank 13F manager | Trim | — | $-23.50M | -370K -31.43% | 807,070 0.58% of shares | medium |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Add | — | $21.06M | +320K +94.82% | 656,608 0.47% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| T. Rowe Price Investment Management, Inc. | Passive13G/A | — |
| Fmr LLC | Passive13G/A | — |
| Vanguard Capital Management | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| CYTK | — | 23282W605 |